PREM-TMD version 1.0
Research type
Research Study
Full title
Development and validation of a patient reported experience measure for temporomandibular disorders patients.
IRAS ID
268196
Contact name
Rachel Leeson
Contact email
Sponsor organisation
University College London
Clinicaltrials.gov Identifier
Z6364106/2019/08/69, Data protection reference number
Duration of Study in the UK
1 years, 9 months, 1 days
Research summary
Summary of Research
Background: Temporomandibular disorders (TMD) are a group of conditions which affect the muscles of the face and the joint which connects the lower jaw to the base of the scull. They can manifest as pain in the joint region and surrounding muscles, clicking of the joint, limited mouth opening, deviation in the jaw movements and headache. Patients with TMD can frequently suffer from psychological distress and anxiety when first experiencing symptoms or develop depression due to the chronic nature of their pain.
Patient experience sits at the heart of the NHS and it has been traditionally measured by satisfaction surveys. Although these are useful sources for public accountability purposes, and giving an impression of the ‘bigger picture’, they can lack sensitivity and objectivity in assessing healthcare services. This leads to the idea of developing patient reported experience measures, which are validated questionnaires that capture the experience of patients in a more focused and objective manner.
Project aims: 1.To develop a patient reported experience measure designed for use in a cohort of patients with temporomandibular disorders
2. To evaluate the psychometric properties of the designed instrument.
3. To study the relationship between various elements of patient experience in the healthcare setting and the potential effect on the patient reported outcomes such as: pain severity scores, quality of life, anxiety and depression.Time scale: 21 months
Clinical significance: The new questionnaire could be implemented into routine clinical practice. The information gathered could be used in research, audits, clinical performance evaluation, quality improvement schemes, improve patient-centred care, clinical practice benchmarking and performance comparisons.
Patient experience sits at the heart of the NHS and it has been traditionally measured by satisfaction surveys. And although they are useful sources for public accountability purposes, and giving an impression of the ‘bigger picture’, they could lack sensitivity and objectivity in assessing healthcare services. This leads to the idea of patient reported experience measures, which are validated questionnaires that capture the experience of patients in a more focused and objective manner.Project aims: 1.To develop a patient reported experience measure designed for use in a cohort of patients with temporomandibular disorders
2. To evaluate the psychometric properties of the designed instrument.
3. To study the relationship between various elements of patient experience in healthcare setting and the potential effect on the patient reported outcomes such as: pain severity scores, quality of life, anxiety and depression.Time scale: 21 months.
Clinical significance: The new questionnaire could be implemented in routine clinical practice. The information gathered could be used to several ends; it could be used in research, audits, clinical performance evaluation, quality improvement schemes, improve patient-centred care, clinical practice bench-marking and performance comparisons.
Summary of Results
“Temporomandibular disorders” or TMD is a term which describes a group of conditions affecting the joint which connects the lower jaw to the base of the skull, the muscles surrounding it, or both. They can manifest in jaw pain, clicking noises, and limitation of mouth opening.
The experience with the healthcare services is a vital part of the NHS, and one way to assess this experience is through patient completed questionnaires known as Patient Reported Experience Measures (PREMs). This research aimed to develop and validate a PREM for patients with TMD.
TMD patients were involved in the development of this questionnaire, where they highlighted the aspects of healthcare most important to them. This was done by having a series of group discussions with 15 TMD patients. The information gathered from these group discussions helped generate the questions of the PREM.
Next, the list of questions was completed by 139 patients with TMD to test its validity and reliability. And indeed, after conducting the relevant analysis, the new PREM was reliable, valid, and suitable for use in a clinical setting.REC name
South East Scotland REC 01
REC reference
19/SS/0130
Date of REC Opinion
20 Dec 2019
REC opinion
Further Information Favourable Opinion